Loading organizations...
Loading organizations...
Biopharmaceutical company providing chemotherapy treatments for cancer.
Intensity Therapeutics has raised $16.5M across 2 funding rounds.
Intensity Therapeutics has raised $16.5M in total across 2 funding rounds.
Intensity Therapeutics has raised $16.5M in total across 2 funding rounds.
Intensity Therapeutics's investors include Declan Doogan, Jim Mellon, Batterson Venture Capital, FastForward Innovations, SalvaRx Group, VCapital.
Intensity Therapeutics has raised $16.5M across 2 funding rounds. Most recently, it raised $6.5M Series B in November 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 2, 2018 | $6.5M Series B | ||
| Jun 28, 2016 | $10.0M Series A | Declan Doogan, Jim Mellon, Batterson Venture Capital, FastForward Innovations, SalvaRx Group, VCapital |